Clinical Trials Browser

Phase 4 × INDUSTRY × pertuzumab × Clear all

NCT02445586 2019-10-29

Safety Study of Pertuzumab (in Combination With Trastuzumab and Docetaxel) in Indian Participants With Breast Cancer

Phase 4 Completed

52 enrolled 41 charts

Breast Neoplasms

NCT01501487 2018-06-28

MINT

Phase 4 Completed

Breast Neoplasms